OP-098 First Month Outcomes in Patients Undergoing Renal Artery Sympathetic Denervation for Refractory Ventricular Tachyarrhythmia




Objective


Sympathetic overactivity plays a critical role in the development, maintenance, and aggravation of ventricular tachyarrhythmia (VT). We aimed to report our case series with 3-month outcomes in patients with implantable cardioverter-defibrillators (ICD) undergoing renal artery sympathetic denervation (RASD) for refractory VT.




Methods


A total of 4 patients with refractory VT underwent RASD. Underlying conditions were ischemic dilated cardiomyopathy (n = 3), and non-ischemic cardiomyopathy (n = 1). Information on the number of VT episodes and device therapies (anti-tachycardia pacing/shocks) in the previous 3 months as well as 3 months after RASD treatment was obtained from ICD interrogation. Renal artery denervation was incomplete in 1 patient. In one patient both renal arteries and accessory left renal artery were denervated.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-011 The Relationship Between Pulmonary Artery Stiffness and Functional Capacity in Patients With Heart Failure
  2. OP-052 Antithrombotic Management in Patients with Atrial Fibrillation and High Risk of Stroke: Results from RAMSES Study
  3. OP-091 Cardioneuroablation in the Treatment of Reflex Syncope: The Results of One Year Follow up: Single Center Experience
  4. PP-026 Evaluation of Characteristics of Patients Hospitalized from the Emergency Service to Cardiology Service

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 27, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-098 First Month Outcomes in Patients Undergoing Renal Artery Sympathetic Denervation for Refractory Ventricular Tachyarrhythmia

Full access? Get Clinical Tree
Get Clinical Tree app for offline access